Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change

Shigeyoshi Honma, Manami Saika, Satoko Ohkubo, Hitoshi Kurose, Norimichi Nakahata

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Abstract

Glial cells express thromboxane A2 receptor, but its physiological role remains unknown. The present study was performed to examine thromboxane A2 receptor-mediated morphological change in 1321N1 human astrocytoma cells. Thromboxane A2 receptor agonists U46619 and STA2 caused a rapid morphological change to spindle shape from stellate form of the cells pretreated with dibutyryl cyclic AMP, but neither carbachol nor histamine caused the change, suggesting that Gq pathway may not mainly contribute to the change. Rho kinase inhibitor Y-27632 inhibited U46619-induced morphological change, and U46619 increased the GTP-bound form of RhoA accompanied with actin stress fiber formation. These responses were reduced by expression of p115-RGS that inhibits G12/13 signaling pathway. U46619 also caused the phosphorylation of extracellular signal-regulated kinase (ERK) and [3H]thymidine incorporation mainly through G12/13-Rho pathway. These results suggest that stimulation of thromboxane A2 receptor causes the morphological change with proliferation mainly through G12/13 activation in glial cells.

Original languageEnglish
Pages (from-to)100-108
Number of pages9
JournalEuropean Journal of Pharmacology
Volume545
Issue number2-3
DOIs
Publication statusPublished - Sep 18 2006

All Science Journal Classification (ASJC) codes

  • Pharmacology

Fingerprint

Dive into the research topics of 'Thromboxane A<sub>2</sub> receptor-mediated G<sub>12</sub>/<sub>13</sub>-dependent glial morphological change'. Together they form a unique fingerprint.

Cite this